SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001906324-24-000025
Filing Date
2024-05-07
Accepted
2024-05-07 16:14:37
Documents
18
Period of Report
2024-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel-20240501.htm   iXBRL 8-K 37242
2 EX-10.1 exhibit101.htm EX-10.1 46983
3 EX-99.1 exhibit991.htm EX-99.1 10978
8 qologoa.jpg GRAPHIC 12781
9 qologob.jpg GRAPHIC 12738
  Complete submission text file 0001906324-24-000025.txt   300737

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20240501.xsd EX-101.SCH 2264
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20240501_def.xml EX-101.DEF 14443
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20240501_lab.xml EX-101.LAB 25398
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20240501_pre.xml EX-101.PRE 15018
21 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20240501_htm.xml XML 2704
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

IRS No.: 874496285 | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-41409 | Film No.: 24922043
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)